Home › Funds › DeepCurrents Investment Group LLC › BBIO

DeepCurrents Investment Group LLC position in BBIO

BRIDGEBIO PHARMA INC · Health Care

DeepCurrents Investment Group LLC reported holding 57,745,000 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q3 2026 13F filing — a position valued at US$89.8M, representing 2.97% of its reported portfolio and ranking #6 among its reported holdings. DeepCurrents Investment Group LLC has disclosed BBIO holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)57.74M sh
Reported value held$89.83M
Portfolio Weight2.97%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How DeepCurrents Investment Group LLC's BBIO position evolved

DeepCurrents Investment Group LLC first disclosed a stake in BBIO in Q3 2023 at 17,855,000 shares (US$13.5M). The position peaked in Q3 2026 at 57,745,000 shares, worth US$89.8M. Across 6 filings, DeepCurrents Investment Group LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 57,745,000 shares valued at US$89.8M — an increase of 7,500,000 shares quarter over quarter.. Notable position changes include a 90% trim in Q1 2024 (shares fell 18% over the following quarter), a 429% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.86M $13.51M New
Q4 2023 17.86M $15.13M Hold
Q1 2024 1.78M $1.69M Reduce
Q1 2026 9.50M $17.14M New
Q2 2026 50.24M $89.75M Add
Q3 2026 57.74M $89.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 38 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$978.6M), Farallon Capital Management (US$800.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has DeepCurrents Investment Group LLC held BBIO?

DeepCurrents Investment Group LLC has disclosed BBIO holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is DeepCurrents Investment Group LLC's current position in BBIO?

As of Q3 2026, DeepCurrents Investment Group LLC holds 57.74M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $89.83M, representing 2.97% of its reported portfolio and ranking #6.

Has DeepCurrents Investment Group LLC been buying or selling BBIO?

In the latest 13F filing (Q3 2026), DeepCurrents Investment Group LLC increased its position in BBIO. The position peaked in Q3 2026 at 57.74M shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, Farallon Capital Management, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.